The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

In the Philippines, access to comprehensive genomic profiling (CGP), circulating tumor DNA (ctDNA), and cell-free DNA (cfDNA) ...

ovarian, and liver cancer, "added Dr Sajjanshetty. “A liquid biopsy can also monitor cancer treatment beyond just detection. Doctors can monitor their response to therapy and identify whether ...

Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...

"Symptoms of ovarian cancer are vague, non-specific, and occur with a variety of conditions," Dr. Priyal Dholakiya, MD, a ...

At just 31 years old, Cameron Gourley had just gotten married when she noticed a lump during her typical self-exam.

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt ...

Previously, Anixa and Moffitt had secured a single patient IND approval for an additional dose for a patient whose biopsy showed ... advance the treatment of ovarian cancer with CAR-T therapy.

Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cancer histologies SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ ...